WM3704 Viable Cells

Artikelnummer: ROC-WM3704-01-0001
Artikelname: WM3704 Viable Cells
Artikelnummer: ROC-WM3704-01-0001
Hersteller Artikelnummer: WM3704-01-0001
Alternativnummer: ROC-WM3704-01-0001
Hersteller: Rockland Immunochemicals
Kategorie: Zellen/Zellkultur
Konjugation: Unconjugated
Alternative Synonym: Melanoma, patient derived tumor, tumor models, skin cancer, xenograft
WM3704 is a metastatic human melanoma cell line that displays a mesenchymal morphology. This cell line was established from a lymph node metastasis site of a patient. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line also expresses mutated PTEN gene and R24H mutation at position 24 in the CDK4 gene. The R24H mutation results in an amino acid substitution at codon 24 in CDK4, from an arginine (R) to histidine (H). This mutation is an activating mutation, as it results in growth advantages by preventing p16 binding, while maintaining the ability of CDK4 to form a functional kinase with cyclin D. WM3704 cells produce xenograft tumors when injected into immunocompromised mice.
Konzentration: 1.0 million cells/mL (Count By Hemocytometer)
Puffer: None
Quelle: Human
Formulierung: Frozen Cell Suspension
Anwendungsbeschreibung: The key applications of these cell lines include genetic studies, xenograft production, drug testing, and drug target discovery. These cell line models can be used in various biological assays, and for identifying critical target genes, and cell signaling pathways.
Human melanoma tumor cells with known gene mutations, disease stage, STR, and RPPA profiling